Genomenon Company
Genomenon develops software tools to rapidly and autonomously prioritize data points for decision-making.
Investors
Estimated Revenue:
$1M to $10M
Funding Status:
Early Stage Venture
Industry:
Clinical Development
Investors Number:
19.0
Last Funding Date:
2022-03-08
Founded Date:
2014-01-01
Headquarters:
Ann Arbor, Michigan, United States
Total Funding:
32773204.0
Last Funding Type:
Series B
Employee Number:
11-50